Y
Yingchun Hou
Researcher at Shaanxi Normal University
Publications - 37
Citations - 748
Yingchun Hou is an academic researcher from Shaanxi Normal University. The author has contributed to research in topics: Cancer & Peptide library. The author has an hindex of 10, co-authored 31 publications receiving 468 citations.
Papers
More filters
Journal ArticleDOI
Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells
Hadi AlShamaileh,Tao Wang,Tao Wang,Dongxi Xiang,Wang Yin,Phuong H.L. Tran,Roberto A. Barrero,Pei Zhuo Zhang,Yong Li,Lingxue Kong,Ke Liu,Shu-Feng Zhou,Yingchun Hou,Sarah Shigdar,Wei Duan +14 more
TL;DR: The results indicate that survivin is one of the key players responsible for the innate chemoresistance of colorectal cancer stem cells and aptamer-mediated targeting of survivin in cancerstem cells in combination with chemotherapeutic drugs constitutes a new avenue to improve treatment outcome in oncologic clinics.
Journal ArticleDOI
Effects of miR-29a and miR-101a expression on myocardial interstitial collagen generation after aerobic exercise in myocardial-infarcted rats
Li Xiao,Huimin He,Lele Ma,Miaomiao Da,Sinan Cheng,Yan Duan,Qian Wang,Huayi Wu,Xigui Song,Wei Duan,Zhenjun Tian,Yingchun Hou +11 more
TL;DR: It is believed that controlled intermittent aerobic exercise is beneficial to the healing and discovery of damaged cardiac tissues and their function after MI and inhibit TGFβ pathway via up-regulation to the expression of microRNAs and miR-101a and finally cause a reduced fibrosis and scar formation in cardiac tissue.
Journal ArticleDOI
The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells
Wang Yin,Dongxi Xiang,Tao Wang,Yumei Zhang,Cuong Viet Pham,Shu-Feng Zhou,Guoqin Jiang,Yingchun Hou,Yimin Zhu,Yinglu Han,Liang Qiao,Phuong H.L. Tran,Wei Duan +12 more
TL;DR: In this article, the authors explored the role of inhibition of MDR1 or ABCG2 in sensitizing liver cancer stem cells to doxorubicin, the most frequently used chemotherapeutic agent in treating liver cancer.
Journal ArticleDOI
A Detailed Protein-SELEX Protocol Allowing Visual Assessments of Individual Steps for a High Success Rate
Tao Wang,Tao Wang,Wang Yin,Hadi AlShamaileh,Yumei Zhang,Phuong H.L. Tran,Tuong Ngoc-Gia Nguyen,Yong Li,Kuisheng Chen,Miaomiao Sun,Yingchun Hou,Weihong Zhang,Qingxia Zhao,Changying Chen,Pei-Zhuo Zhang,Wei Duan +15 more
TL;DR: An improved protein-SELEX procedure is presented for simplified and highly efficient isolation of aptamers against protein targets, and a simplified sample preparation method for MiSeq-based next-generation sequencing is introduced.
Journal ArticleDOI
ANXA2 enhances the progression of hepatocellular carcinoma via remodeling the cell motility associated structures
Hongyan Shi,Li Xiao,Wei Duan,Huimin He,Lele Ma,Miaomiao Da,Yan Duan,Qian Wang,Huayi Wu,Xigui Song,Yingchun Hou +10 more
TL;DR: The results indicate that ANXA2 plays an important role to enhance the malignant behaviors of HCC cells, and the enhancement is closely based on its remodeling to cell structures.